Following the Use of Gel Prosethetics in Breast Reconstruction

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Reconstruction or Revision

NCT00585884CI-TRIAL-00068799completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Following placement of silicone breast prosthetics for reconstruction

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Breast Cancer	Malignant Breast Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: Female
Minimum age: 18 Years
Maximum age: 80 Years

Show eligibility criteria text

Inclusion Criteria:

* Women undergoing breast surgery

Exclusion Criteria:

* Collagen vascular disease, Scleroderma

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Feb 1, 2001
Primary completion: Sep 23, 2013
Completion: Sep 23, 2013
First posted: Jan 3, 2008
Last update posted: Aug 14, 2023
Enrollment: 3 (actual)
Lead sponsor: University of California, Irvine OTHER
Collaborators: Mentor Worldwide, LLC
Keywords: Reconstruction, Silicone prostheses

Data updated 22 days agoSource updated Aug 14, 2023source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
United States	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.